Endocrine Society Journals Earn Higher 2020 Impact Factors

endocrine reviews dec 2020

Endocrine Society Journals experienced large Impact Factor increases, led by Endocrine Reviews, according to Clarivate’s recently released annual Journal Citation Report (JCR) for 2020. 

A highly regarded metric used to measure the success of scholarly journals, the 2020 Impact Factor is calculated by tracking how many times articles that a journal published in 2018 and 2019 were cited by authors during 2020. The number of citations is then divided by the total number of citable articles published in that journal in 2018 and 2019 to arrive at the Impact Factor. 

I’m delighted that our journals’ scores improved so much since the last Impact Factor report,” says Daniel Spratt, MD, chair of the Endocrine Society’s Publications Core Committee. “The recognition is well deserved and a result of all the hard work of our authors, reviewers, and editors to publish the most innovative research in the field.” 

Endocrine Reviews saw the biggest increase in Impact Factor among the Society’s journals, rising from 14.661 in 2019 to 19.871 in 2020, and is ranked fourth out of more than 175 journals in the Endocrinology and Metabolism JCR category. The journal publishes bimonthly comprehensive, authoritative, and timely review articles balancing both experimental and clinical endocrinology themes. 

The Journal of Clinical Endocrinology and Metabolism’s (JCEM) Impact Factor increased from 5.399 in 2019 to 5.958 in 2020 and continues to be the most cited journal in Endocrinology and Metabolism. JCEM is the world’s leading peer-reviewed journal for endocrine clinical research and clinical practice. 

Endocrinologythe Endocrine Society’s flagship basic science journal, saw its Impact Factor increased from 3.934 to 4.736, and has the highest cited half-life in Endocrinology and Metabolism 

The Society’s newest journal, the open access Journal of the Endocrine Societylaunched in 2017is listed in indexes including Scopus and Clarivate’s Emerging Sources Citation Index, and is a candidate to receive its first Impact Factor next year. 

You may also like

  • Members in the News: Joshua Klopper, MD, Named Veracyte’s Medical Director of Endocrinology

    Endocrine Society member Joshua Klopper, MD, has been appointed medical director of Endocrinology at the genomic diagnostics company Veracyte.  Klopper is a nationally recognized endocrinologist who specializes in the evaluation and management of thyroid nodules and thyroid cancer. He joins Veracyte today, reporting to another Society member, Richard T. Kloos, MD, Veracyte’s executive medical director….

  • Movers & Shakers: Lab Relocation During a Pandemic

    Moving is always stressful. Just imagine factoring in social distancing protocols, adhering to California’s earthquake safety standards, and pausing your research to get it done. Joy Y. Wu, MD, PhD, talks to Endocrine News about moving her research lab at Stanford University under less-than-ideal circumstances but she and her team got it done with a…

Find more in